Vascular Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients
Phase 2
Completed
- Conditions
- Diabetic Nephropathy
- Interventions
- Drug: VPI-2690B high doseDrug: VPI-2690B low doseDrug: VPI-2690B medium doseDrug: Placebo to match VPI-2690B
- First Posted Date
- 2014-09-26
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Vascular Pharmaceuticals, Inc.
- Target Recruit Count
- 165
- Registration Number
- NCT02251067
News
No news found